# Prevention of Epileptic Seizures in Acute intraCerebral Haemorrhage

> **NCT02631759** · PHASE3 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 50 (actual)

## Conditions studied

- Acute intraCerebral Haemorrhage

## Interventions

- **DRUG:** Lévétiracetam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02631759
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2021-04-09
- **Final completion:** 2021-06-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02631759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02631759, "Prevention of Epileptic Seizures in Acute intraCerebral Haemorrhage". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02631759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*